Brighthouse Financial Pref Share BHFAO 6.75 Perp 06/25/25 B | 8-K: FY2025 Q1 EPS: USD -5.04

LB filings
2025.05.08 20:24
portai
I'm PortAI, I can summarize articles.

EPS: As of FY2025 Q1, the actual value is USD -5.04.

EBIT: As of FY2025 Q1, the actual value is USD -354 M.

Segment Revenue

  • Annuity Sales: $2.3 billion, including $2.0 billion in sales of Shield Level Annuities.
  • Life Sales: $36 million, reflecting growth in the company’s life insurance suite.
  • Annuities: Adjusted revenues of $1,344 million for the three months ended March 31, 2025.
  • Life: Adjusted revenues of $291 million for the three months ended March 31, 2025.
  • Run-off: Adjusted revenues of $367 million for the three months ended March 31, 2025.
  • Corporate & Other: Adjusted revenues of $154 million for the three months ended March 31, 2025.

Operational Metrics

  • Net Loss: $294 million, or $5.04 per diluted share, compared to a net loss of $519 million, or $8.22 per diluted share, in the first quarter of 2024.
  • Adjusted Earnings: $235 million, or $4.01 per diluted share, compared to an adjusted loss of $98 million, or $1.56 per diluted share, in the first quarter of 2024.
  • Corporate Expenses: $239 million, up from $207 million in the first quarter of 2024.

Cash Flow

  • Holding Company Liquid Assets: $1.0 billion.
  • Cash and Cash Equivalents: $4,667 million as of March 31, 2025.

Unique Metrics

  • Estimated Combined RBC Ratio: Between 420% and 440%.
  • Combined Risk-Based Capital Ratio: 420%-440% as of March 31, 2025.

Outlook / Guidance

Brighthouse Financial anticipates volatility in net income due to differences between hedge targets and GAAP reserves impacted by market performance. The company aims to maintain a robust level of holding company liquid assets and expects continued growth in sales of its Shield Level Annuities Product Suite. Brighthouse Financial anticipates future actions and financial performance may be influenced by various risks and uncertainties, including actuarial assumptions, market risk, and regulatory changes.